Efficacy and Safety of Dapagliflozin for the Hospital Management of Patients With Type 2 Diabetes

Conditions:   Type2diabetes;   Coronary Artery Disease Interventions:   Drug: Dapagliflozin;   Drug: Glargine Sponsor:   Medanta, The Medicity, India Not yet recruiting

Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials